glp-1 science Companies seek a second obesity treatment revolution—in pill form | Science has named the development

[80] were able to show how both topical and systemic liraglutide administration prevented retinal degeneration in db/db mice

These injections are particularly beneficial for those with a body mass index (BMI) of 27 or higher

Lim R, Beekley A, Johnson DC, Davis KA

The delayed gastric emptying caused by GLP-1 agonists might theoretically contribute to reduced alcohol consumption by altering absorption kinetics and the subjective experience of intoxication, though this hypothesis requires human pharmacokinetic studies for validation

Medical Citation URL Spitery A, Elder MJ, Farhat N, Mohammad I, Lobkovich A

For Willow subscribers currently using compounded tirzepatide, this creates uncertainty